SCHEMBL3860122

SCHEMBL3860122

COc1cc(/C=C/C(=O)C(C)(C)C(=O)C(C)(C)C)ccc1O[Si](C)(C)C(C)(C)C

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.64
KDM4E B2RXH2 1/20 0.48
ALDH1A1 P00352 1/20 0.48
HPGD P15428 1/20 0.48
ALOX15 P16050 1/20 0.48
MAPK1 P28482 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
HSD17B10 Q99714 1/20 0.48
NFE2L2 Q16236 1/20 0.47
ABCG2 Q9UNQ0 2/20 0.46
MEN1 O00255 1/20 0.46
CYP1A1 P04798 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP1B1 Q16678 1/20 0.44
JUN P05412 1/20 0.44
NFKB1 P19838 1/20 0.44
DRD2 P14416 1/20 0.43
FDPS P14324 2/20 0.43
PTGES O14684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3860127 1.00 KMT2A (0.64) KMT2AKDM4EALDH1A1HPGDALOX15
SCHEMBL9553571 0.84 FDPS (0.61) KMT2AKDM4EALDH1A1HPGDALOX15
SCHEMBL2553988 0.84 KDM4E (0.69) KMT2AKDM4EALDH1A1HPGDALOX15
SCHEMBL2553992 0.84 KDM4E (0.69) KMT2AKDM4EALDH1A1HPGDALOX15
SCHEMBL14342653 0.84 FDPS (0.61) KMT2AKDM4EALDH1A1HPGDALOX15
SCHEMBL30656553 0.84 KDM4E (0.69) KMT2AKDM4EALDH1A1HPGDALOX15
SCHEMBL17529412 0.83 KMT2A (0.56) KMT2AKDM4EALDH1A1HPGDALOX15
SCHEMBL23665036 0.82 KMT2A (0.54) KMT2AKDM4EALDH1A1HPGDALOX15
SCHEMBL3857387 0.81 NFE2L2 (0.64) KMT2AKDM4EALDH1A1HPGDALOX15
SCHEMBL3857391 0.81 NFE2L2 (0.64) KMT2AKDM4EALDH1A1HPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7589123-B2 Chemical compounds PHYTOPHARM PLC (GB) 2009-09-15 US disclosed
CN-101511350-A Dioxo-alkanes and dioxo-alkenes PHYTOPHARM PLC (GB) 2009-08-19 CN disclosed
US-20080045591-A1 Chemical Compounds VECTURA LIMITED (GB) 2008-02-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080045591-A1 Chemical Compounds CYP11B1, CYP11B2, CYP2S1 KMT2A 3581/4885KDM4E 4332/4885ALDH1A1 936/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.